Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Bibiana Quirant"'
Autor:
Aina Teniente-Serra, Eduarda Pizarro, Bibiana Quirant-Sánchez, Marco A. Fernández, Marta Vives-Pi, Eva M. Martinez-Caceres
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Frontiers in Immunology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
T- and B-lymphocytes play an important role in the pathogenesis of type 1 diabetes (T1D), a chronic disease caused by the autoimmune destruction of the insulin-producing cells in the pancreatic islets. Flow cytometry allows their characterization in
Autor:
Bibiana Quirant-Sánchez, Ignacio Blanco, Joan Matllo, Monica Piña, Oriol Estrada, Maria Dolade, Eva Martínez-Cáceres, Jaume Barallat, Gema Fernández-Rivas, Victoria González
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
PLoS ONE, Vol 15, Iss 12, p e0244348 (2020)
PLoS ONE
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Universitat Autònoma de Barcelona
PLoS ONE, Vol 15, Iss 12, p e0244348 (2020)
PLoS ONE
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Background The rapid spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) around the world has caused a global pandemic, infecting millions of individuals, with an unprecedented impact in health care systems worldwide. Healthcare wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d015b539da7785bb23b1bd4d5dd1c1a
https://ddd.uab.cat/record/253220
https://ddd.uab.cat/record/253220
Autor:
Aina Teniente-Serra, Juan Navarro-Barriuso, María José Mansilla, Eva Martínez-Cáceres, Cristina Ramo-Tello, Silvia Presas-Rodríguez, Bibiana Quirant-Sánchez
Publikováno v:
CNS NEUROSCIENCE & THERAPEUTICS
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
CNS Neuroscience & Therapeutics
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
CNS Neuroscience & Therapeutics
Aim Dimethyl fumarate (DMF) is one of the most promising therapies for relapsing‐remitting multiple sclerosis (RRMS) patients since it has shown immunomodulatory and neuroprotective effects. However, a percentage of RRMS patients do not exhibit an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d55a011fb37e551af898c75042b3c51e
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2656
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2656
Autor:
Bibiana, Quirant-Sánchez, Silvia, Presas-Rodriguez, María José, Mansilla, Aina, Teniente-Serra, José V, Hervás-García, Luis, Brieva, Ester, Moral-Torres, Antonio, Cano, Elvira, Munteis, Juan, Navarro-Barriuso, Eva M, Martínez-Cáceres, Cristina, Ramo-Tello
Publikováno v:
Mediators of Inflammation
Peripheral blood biomarkers able to predict disease activity in multiple sclerosis (MS) patients have not been identified yet. Here, we analyzed the immune phenotype of T lymphocyte subpopulations in peripheral blood samples from 66 RRMS patients und
Autor:
Alex Sánchez-Pla, Eva Martínez-Cáceres, Cristina Ramo-Tello, Aina Teniente-Serra, Juan Navarro-Barriuso, María José Mansilla, Bibiana Quirant-Sánchez, Mar Naranjo-Gómez
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Scientific Reports
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Universidad de Barcelona
Scientific Reports
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Tolerogenic dendritic cell (tolDC)-based therapies have become a promising approach for the treatment of autoimmune diseases by their potential ability to restore immune tolerance in an antigen-specific manner. However, the broad variety of protocols
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0276d9afb303eba5291c3741ae9fc732
https://ddd.uab.cat/record/253670
https://ddd.uab.cat/record/253670
Autor:
Ester Moral-Torres, Antonio Cano, Cristina Ramo-Tello, Elvira Munteis, Eva Martínez-Cáceres, Aina Teniente-Serra, Luis Brieva, José V. Hervás‐García, María José Mansilla, Juan Navarro-Barriuso, Silvia Presas-Rodríguez, Bibiana Quirant-Sánchez
Publikováno v:
CNS NEUROSCIENCE & THERAPEUTICS
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Aims Fingolimod, an orally active immunomodulatory drug for relapsing-remitting multiple sclerosis (RRMS), sequesters T cells in lymph nodes through functional antagonism of the sphingosine-1-phosphate receptor, reducing the number of potential autor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cca87481319666f6c6dacca393e7f30e
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5337
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5337
Autor:
Joan, Puñet-Ortiz, José Vicente, Hervás-García, Aina, Teniente-Serra, Antonio, Cano-Orgaz, Maria José, Mansilla, Bibiana, Quirant-Sánchez, Juan, Navarro-Barriuso, Marco A, Fernández-Sanmartín, Silvia, Presas-Rodríguez, Cristina, Ramo-Tello, Eva María, Martínez-Cáceres
Publikováno v:
Cytometry. Part B, Clinical cytometry. 94(2)
In natalizumab-treated relapsing-remitting MS (RRMS) patients, various extended interval dosing strategies are under evaluation to minimize severe treatment-associated side effects, mainly progressive multifocal leukoencephalopathy development. Up to
Autor:
Aina Teniente-Serra, Laia Grau-López, Eva Martínez-Cáceres, Bibiana Quirant-Sánchez, Jose Vicente Hervas, María José Mansilla, Cristina Ramo-Tello
Summary Aims Fingolimod, oral treatment for relapsing–remitting multiple sclerosis (RRMS), is an agonist of sphingosine and its metabolite S1P that binds their receptors, blocking the egress of lymphocytes from lymph nodes. The aim of this study wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3ff16f745d6657aa60e19114bc2924e
https://europepmc.org/articles/PMC6492868/
https://europepmc.org/articles/PMC6492868/